StockSelector.com
  Research, Select, & Monitor Wednesday, March 22, 2017 10:13:07 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup

Market Movers
Technicals
Valuations
Growth
  Estimated Earnings
  Historic Earnings
  Estimated Revenue
  Historic Revenue
  Cash
  Dividend
  Shares
Fundamentals
Stock Options

ACADIA PHARMACEUTICALS INC. ACAD 28,783.33% N/A

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson's disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.
Company Ticker History Revenue Growth History Growth Rate
TESARO Inc. TSRO 13,906.25% N/A
Idera Pharmaceuticals Inc IDRA 6,380.00% N/A
Aratana Therapeutics Inc PETX 5,569.12% N/A
Sunshine Heart Inc SSH 2,050.00% N/A
CRISPR THERAPTC CRSP 1,964.00% N/A
Applied Genetic Technologies Co AGTC 1,915.32% N/A
Fortress Biotech Inc. FBIO 1,816.28% N/A
Cogent Inc COGT 1,226.05% N/A
WAVE LIFE SCI WVE 893.33% N/A
AYTU BIOSCIENCE AYTU 884.62% N/A
Titan Pharmaceuticals, Inc. TTNP 802.40% N/A
InterCept, Inc ICPT 797.48% N/A
PROVISION HOLDG PVHO 778.95% N/A
Senseonics Holdings, Inc. SENS 725.00% N/A
Novogen Ltd. NVGN 700.00% N/A
Progenics Pharmaceuticals Inc. PGNX 699.88% N/A
Pluristem Therapeutics PSTI 650.00% N/A
IRSA Inversiones y Representac IRS 620.24% (279.25%)
Foamix Pharmaceuticals Ltd. FOMX 550.59% N/A
OPNET Technologies Inc. OPNT 538.71% N/A
Coherus Biosciences, Inc. CHRS 532.86% N/A
Pfenex Inc. PFNX 528.29% N/A
8point3 Energy Partners LP CAFD 474.11% N/A
Oaktree Capital Group LLC OAK 457.55% 91.98%
Legal & General Group Plc 10p LGGNY 444.46% 3.62%
Biocept Inc BIOC 427.87% N/A
Hertz Global Holdings, Inc. HTZ 424.55% (78.22%)
Exelixis, Inc. EXEL 415.07% N/A
R1 RCM INC RCM 405.42% N/A
Viveve Medical, Inc. VIVE 392.41% N/A
Greenlight Capital Re Ltd. GLRE 378.16% N/A
Cheniere Energy, Inc. LNG 373.69% N/A
Ocera Therapeutics, Inc. OCRX 369.23% N/A
Juno Therapeutics Inc. JUNO 335.57% N/A
Sarepta Therapeutics, Inc. SRPT 333.60% N/A


Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2017 StockSelector.com. All rights reserved.